De PhD y otros demonios. Sandra Bermeo
Disguise as an evasive stratagem of parasitic organisms. Parasitology. 1984 Aug; 88 (Pt 4):597-611.
18. Schmidt J. Glycans with N-acetyllactosamine type 2-like residues covering adult Schistosoma mansoni, and glycomimesis as a putative mechanism of immune evasion. Parasitology. 1995 Sep; 111 (Pt 3):325-36.
19. Riley EM, Jobe O, Whittle HC. CD8+ T cells inhibit Plasmodium falciparum -induced lymphoproliferation and gamma interferon production in cell preparations from some malaria-immune individuals. Infect Immun. 1989 Apr;57(4):1281-4.
20. Dermine JF, Goyette G, Houde M, Turco SJ, Desjardins M. Leishmania donovani lipophosphoglycan disrupts phagosome microdomains in J774 macrophages. Cell Microbiol. 2005 Sep;7(9):1263-70.
21. Ota H, Takashima Y, Matsumoto Y, Hayashi Y, Masumoto Y. Pretreatment of macrophages with the combination of IFN-gamma and IL-12 induces resistance to Leishmania major at the early phase of infection. J Vet Med Sci. 2008 Jun;70(6):589-93.
22. Del Prete G, Maggi E, Romagnani S. Human Th1 and Th2 cells: Functional Properties, mechanisms of regulation, and role in disease. Lab Invest. 1994 Mar;70(3):299-306.
23. Fenton A, Lamb T, Graham AL. Optimality análisis of Th1/Th2 immune responses during microparasite-macroparasite co-infection, with epidemiological feedbacks. Parasitology. 2008 Jun;135(7):841-53.
24. Negrão-Corrêa D. Imporance of immunoglobulin E (IgE) in the protective mechanism against gastrointestinal nematode infection: looking at the intestinal mucosae. Rev Inst Med Trop Sao Paulo. 2001 Sep-Oct;43(5):291-9.
25. Liesenfeld O, Dunay IR, Erb KJ. Infection with Toxoplasma gondii reduces established and developing Th2 responses induced by Nippostrongylus braziliensis infection. Infect Immun. 2004 Jul;72(7):3812-22.
26. Cooper PJ, Ayre G, Martin C, Rizzo JA, Ponte EV, Cruz AA. Geohelminth infections: a review of the role of IgE and assessment of potential risks of anti-IgE treatment. Allergy. 2008 Apr;63(4):409-17.
27. MacDonald AS, Araujo MI, Pearce EJ. Immunology of parasitic helminth infections. Infect Immun. 2002 Feb;70(2):427-33.
28. Castro GA. Immunophysiology of enteric parasitism. Parasitol Today. 1989; 5(1):11-9.
29. Okerengo AA, Adeniyi A, Williams AI, Osunkoya O. Studies on the immunopathology of the nephritic syndrome associated with Plasmodium malariae. 1. Serum levels of an immune adherence inhibitor. Afr J Med Med Sci. 1980 Mar-Jun;9(1-2):43-7.
30. Holmes PH. Pathophysiology of parasitic infections. Parasitology. Parasitology. 1987;94 Suppl:S29-51.
31. Thompson PE, Graedel SK, Schneider CR, Stucki WB, Gordon RM. Preparation and evaluation of standardized amoeba antigen from axenic cultures of Entamoeba histolytica. Bull World Health Organ. 1968;39(3):349-65.
32. Diamond LS, Clark CG. A redescription of Entamoeba histolytica Schaudinn, 1903 (Emended Walker 1911) separating it from Entamoeba dispar Brumpt, 1925. J Eukaryot Microbiol. 1993 May-Jun;40(3):340-4.
33. García-Agudo L, Rodríguez-Iglesias M. [ELISA test for the detection of Entamoeba histolytica in stool specimens]. Enferm Infecc Microbiol Clin. 2007 Dec;25(10):657.
34. Donelson JE. Antigenic variation and the African trypanosome genome. Acta Trop. 2003 Mar;85(3):391-404.
35. Miller TA. Vaccination against the canine hookworm diseases. Adv Parasitol. 1971;9:153-83.
36. Drew DR, Lightowlers M, Strugnell RA. Humoral immune responses to DNA vaccines expressing secreted, membrane bound and non-secreted forms of the Taenia ovis 45W antigen. Vaccine. 2000 May 22;18(23):2522-32.
37. Molinari JL, Soto R, Tato P, Rodriguez D, Retana A, Sepúlveda J, et al. Immunization against porcine cysticercosis in an endemic area in Mexico: a field and laboratory study. Am J Trop Med Hyg. 1993 Oct;49(4):502-12.
38. Weis JB. DNA probes and PCR for diagnosis of parasitic infection. Clin Microbiol Rev. 1995 Jan;8(1):113-30.
39. Barker DC. Molecular approaches to DNA diagnosis. Parasitology. 1989;99 Suppl:S125-46.
40. Botero D. Persistencia de las parasitosis intestinales endémicas en América Latina. Bol Of Sanit Panam. 1981; 90(1):39-47.
41. Hotez PJ. Global Christianity and the control of its neglected tropical diseases. PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3135.
42. Apt W. Helmintiasis intestinales humanas en América Latina. Prevalencia actual y sus factores contribuyentes. Parasitol al día 1987; 11:155-166.
43. Galán R, Agualimpia C, Corredor-Arjona A, Cáceres-Vega E. Parasitismo Intestinal. Estudio de recursos humanos para la salud y educación médica en Colombia. Ministerio de Salud. Asociación de Facultades de Medicina. 1969.
44. Corredor A, Arciniegas E, Hernández CA. Parasitismo Intestinal. Bogotá: Ministerio de Salud, Instituto Nacional de Salud. Colombia. 2002.
45. CE, López MC, Reyes P, Gómez JE, Corredor A, Agudelo C. Diferenciación de Entamoeba histolytica y Entamoeba dispar en muestras de materia fecal por detección de adhesina de E. histolytica mediante ELISA. Biomédica. 2001; 21(2):167-71.
46. WHO-UNICEF. World Malaria Report. En: WHO [en línea] 2005 [consultado en el 2005]. Disponible en:
47. Guhl F, Lazdins-Helds J. Reporte sobre la enfermedad de Chagas. Reporte del grupo de trabajo científico sobre la enfermedad de Chagas. 17-20 de abril de 2005. Buenos Aires, Argentina: OMS/TDR; 2007.
48. Padilla JC. Situación de la enfermedad de Chagas en Colombia. En: Guhl F, editor. Memorias del primer taller internacional sobre control de la enfermedad de Chagas. Bogotá: Universidad de los Andes. Colombia; 2005. p. 19-24.
49. Parra GJ, Restrepo M, Restrepo BN, Domínguez J. Estudio de tripanosomiasis americana en dos poblados indígenas de la Sierra Nevada de Santa Marta. Revista CES Medicina. 2004; 18(1):43-50.
50. Restrepo, M, Parra, GJ, Restrepo C. Morbilidad de la enfermedad de Chagas en la Sierra Nevada de Santa Marta. En: Guhl F, Jaramillo CA, editores. Curso Taller Internacional – Sistemas de Información Geográfica, Sensores Remotos y Genética Poblacional de Vectores y Parásitos aplicados al control de la enfermedad de Chagas. Bogotá: Universidad de los Andes. 2002; p. 121-4.
51. Montresor A, Gyorkos TW, Crompton DWT, Bundy DAP, Savioli L. Monitoreo de los programas de control de helmintiasis. Washington D.C: OPS/HCP/ HCT/P/177/01. 2001.
52. Savioli L, Stansfield S, Bundy DA, Mitchell A, Bhatia R, Engels D et al. Schistosomiasis and soil-transmitted helminth infections: forging control efforts. Trans R Soc Trop Med Hyg. 2002 Nov-Dec;96(6):577-9.
53. WHO/Department of Communicable Disease Prevention, Control and Eradication. Prevention and control of schistosomiasis and soil-transmitted helminthiasis: WHO Technical Report Series N° 912. Ginebra; 2002.
54. Zani LC, Favre TC, Pieri OS, Barbosa CS. Impact of antihelminthic treatment on infection by Ascaris lumbricoides, Trichuris trichiura and hookworms in Covas, a rural community of Pernambuco, Brazil. Rev Inst Med Trop Sao Paulo. 2004 Mar-Apr;46(2):63-71.
| Unidad 2 | Parasitosis intestinales por protozoos |